Literature DB >> 3570458

Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.

A Moos, T Hackstadt.   

Abstract

We compared the relative infectivity and virulence of lipopolysaccharide (LPS) variants of the Nine Mile strain of Coxiella burnetii with those of the Priscilla strain, a representative of endocarditis-type strains. In agreement with results of previous studies, Nine Mile phase I (9mi/I) organisms were highly infectious, eliciting seroconversion and fever with inocula containing as few as four organisms. Viable 9mi/I was recovered from the spleens of infected animals 30 days postinfection. Nine Mile phase II (9mi/II) organisms did not elicit fever or seroconversion except with very large inocula, and viable organisms could not be recovered at 30 days postinfection. The Nine Mile/Crazy variant, bearing the intermediate-type LPS, was also highly infectious, as determined by fever response and seroconversion, although, as with 9mi/II, viable organisms could not be recovered 30 days postinfection. The Priscilla strain in phase I (Pris/I) was as infectious as 9mi/I, as determined by seroconversion and its presence in the spleen 30 days postinfection; but in contrast to 9mi/I, more than 10(5) Pris/I isolates were required to induce fever. The temporal appearances of anti-phase I and II antibodies were similar for the two strains. A variety of serological techniques measuring antibody response against whole-cell and purified LPS antigens in agglutination, immunofluorescence, enzyme-linked immunosorbent, and immunoblot assays did not demonstrate sufficient specificity to distinguish between 9mi/I and Pris/I infections. Results of vaccine cross-challenge experiments showed a significant degree of protection between homologous and heterologous challenge strains. protection between homologous

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3570458      PMCID: PMC260482          DOI: 10.1128/iai.55.5.1144-1150.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The biologic properties of Coxiella burnetii isolated from rodents collected in Utah.

Authors:  H G STOENNER; D B LACKMAN
Journal:  Am J Hyg       Date:  1960-01

2.  Biological properties of the M-44 strain of Coxiella burneti.

Authors:  J W Johnson; G A Eddy; C E Pedersen
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

3.  Use of hoechst dyes 33258 and 33342 for enumeration of attached and planktonic bacteria.

Authors:  J H Paul
Journal:  Appl Environ Microbiol       Date:  1982-04       Impact factor: 4.792

4.  Appearance of cellular and humoral immunity in guinea pigs after infection with Coxiella burnetii administered in small-particle aerosols.

Authors:  R A Kishimoto; G T Burger
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

5.  A microagglutination technique for detection and measurement of rickettsial antibodies.

Authors:  P Fiset; R A Ormsbee; R Silberman; M Peacock; S H Spielman
Journal:  Acta Virol       Date:  1969-01       Impact factor: 1.162

6.  Assay of Coxiella burnetii by enumeration of immunofluorescent infected cells.

Authors:  N Hahon; K O Cooke
Journal:  J Immunol       Date:  1966-10       Impact factor: 5.422

7.  Demonstration of inapparent infection with disease agents common to animals and man.

Authors:  H J Wisniewski; M M Kleiman; D B Lackman; E R Krumbiegel
Journal:  Health Lab Sci       Date:  1969-07

8.  Limits of rickettsial infectivity.

Authors:  R Ormsbee; M Peacock; R Gerloff; G Tallent; D Wike
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

9.  Different sugar compositions of lipopolysaccharides isolated from phase I and pure phase II cells of Coxiella burnetii.

Authors:  S Schramek; H Mayer
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

10.  Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.

Authors:  T Hackstadt; M G Peacock; P J Hitchcock; R L Cole
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

View more
  107 in total

1.  Use of monoclonal antibodies to lipopolysaccharide for antigenic analysis of Coxiella burnetii.

Authors:  Akitoyo Hotta; Midori Kawamura; Ho To; Masako Andoh; Tsuyoshi Yamaguchi; Hideto Fukushi; Ken-Ichi Amano; Katsuya Hirai
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages.

Authors:  Dale Howe; Jeffrey G Shannon; Seth Winfree; David W Dorward; Robert A Heinzen
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

3.  The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates.

Authors:  Daniel E Voth; Paul A Beare; Dale Howe; Uma M Sharma; Georgios Samoilis; Diane C Cockrell; Anders Omsland; Robert A Heinzen
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

4.  Coxiella burnetii Inhibits Neutrophil Apoptosis by Exploiting Survival Pathways and Antiapoptotic Protein Mcl-1.

Authors:  Rama Cherla; Yan Zhang; Lindsey Ledbetter; Guoquan Zhang
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

5.  Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.

Authors:  Guoquan Zhang; Ho To; Kasi E Russell; Laura R Hendrix; Tsuyoshi Yamaguchi; Hideto Fukushi; Katsuya Hirai; James E Samuel
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.

Authors:  Chen Chen; Erin J van Schaik; Anthony E Gregory; Adam Vigil; Phillip L Felgner; Laura R Hendrix; Robert Faris; James E Samuel
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

7.  Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.

Authors:  A A Izzo; B P Marmion; T Hackstadt
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

8.  Efficient method of cloning the obligate intracellular bacterium Coxiella burnetii.

Authors:  Paul A Beare; Dale Howe; Diane C Cockrell; Robert A Heinzen
Journal:  Appl Environ Microbiol       Date:  2007-04-27       Impact factor: 4.792

Review 9.  Coxiella type IV secretion and cellular microbiology.

Authors:  Daniel E Voth; Robert A Heinzen
Journal:  Curr Opin Microbiol       Date:  2009-01-12       Impact factor: 7.934

Review 10.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.